Drug Discovery & Pharmaceuticals

RSS

PRISM ALS: A new global collaboration to expand patient-derived stem cell models and accelerate treatments

A new global initiative launched today aims to close a critical gap in ALS/MND drug discovery - current cell models used for testing treatments do not currently reflect the diverse nature of the disease - that affects both researchers developing therapies and the people urgently waiting for them.

From ALS Therapy Development Institute (ALS TDI) 1 Apr 2026

Purdue University accelerates rare disease drug discovery with the WELLJET dispenser stacker

Scientists at Purdue University are using the WELLJET dispenser stacker from INTEGRA Biosciences to increase the speed, consistency and scale of drug screening for rare and neglected parasitic diseases.

1 Apr 2026

Semarion secures $3.8 million to scale next-generation cell assay technology and accelerate pharma adoption

Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today announced it has raised $3.8 million USD (£2.9 million GBP).

From Semarion 31 Mar 2026

Nuclera launches GPCR-focused nanodisc panel to streamline membrane protein production

Nuclera, the biotechnology company enabling rapid access to high-quality proteins, today announced the launch of its nanodisc panel to support screening and scale-up of G-Protein Coupled Receptors (GPCRs).

From Nuclera 30 Mar 2026

iXCells Biotechnologies joins international collaboration to evaluate chemotherapeutic toxicity in human organoids

iXCells Biotechnologies ("iXCells"), a leading provider of human cell-based solutions and custom iPSC services, today announced it has entered an international collaboration with Rosebud Biosciences ("Rosebud"), Kantify, and Incite to evaluate off-target chemotherapeutic toxicities in patient-specific organoids.

From iXCells Biotechnologies 25 Mar 2026

Optibrium introduces graphical interface for QuanSA to enhance ligand-based affinity predictions

Optibrium, a leading developer of software and AI solutions for molecular design, today announced a new QuanSA™ plugin for PyMOL, providing an intuitive Graphical User Interface (GUI) for its ligand-based binding affinity prediction method, part of the Company's BioPharmics 3D molecular modelling platform.

From Optibrium Ltd. 25 Mar 2026

New nanoparticle system boosts scalable production of therapeutic exosomes

Researchers from Xi'an Jiaotong-Liverpool University (XJTLU) in China have developed a streamlined process that makes it easier to produce tiny therapeutic particles released by cells, called exosomes, which are being explored as a new type of medical treatment.

24 Mar 2026

Insilico and ASKA partner to advance AI-driven gynecological drug discovery

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced a strategic research collaboration with ASKA Pharmaceutical Co., Ltd. ("ASKA"), a specialized pharmaceutical company with a strong focus on internal medicine, obstetrics, and gynecology.

24 Mar 2026

Machine learning speeds up AMP discovery for treating ulcerative colitis

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by recurrent intestinal inflammation, abdominal pain and diarrhea.

23 Mar 2026

LGM Pharma expands U.S. manufacturing, bringing total investment to $15M across Texas and Colorado sites

LGM Pharma, a leading provider of tailored API sourcing, contract analytical testing, and CDMO services for the full drug product lifecycle, today announced the second phase of its CDMO growth strategy, committing an additional $9 million to its facilities in Rosenberg, Texas, and Colorado Springs, Colorado.

From LGM Pharma 19 Mar 2026

Scientists turn plastic waste into Parkinson’s drug levodopa using engineered bacteria

Researchers engineered a two-strain microbial system that converts PET-derived terephthalic acid into levodopa, overcoming key bottlenecks in transport and enzyme inhibition. The proof-of-concept process achieves high yields under mild conditions and demonstrates a potential route for upcycling plastic waste into valuable pharmaceuticals.

17 Mar 2026

New release Wiley's Mass Spectra of Designer Drugs 2026 expands coverage of emerging novel psychoactive substances

Wiley, a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today announced the 2026 release of Mass Spectra of Designer Drugs, the essential GC‑MS spectral database used by forensic laboratories worldwide for the rapid identification of illicit substances.

From John Wiley and Sons - Scientific Publishers 16 Mar 2026

Researchers achieve breakthrough in the production of vital chemotherapy agent

An international team of researchers has achieved a breakthrough in the production of doxorubicin, a vital chemotherapy agent.

13 Mar 2026

Review examines clinical trial phases in drug development

Announcing a new article publication for BIO Integration journal. Clinical trials bridge basic research and clinical application, serving as essential steps in drug development.

13 Mar 2026

Cambridge’s LED breakthrough reinvents drug synthesis

Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than toxic chemicals – a discovery that could accelerate and improve how medicines are designed and made.

13 Mar 2026

ELRIG announces Prof Hazel Screen and Dr Dave Powell as keynote speakers for Advances in Cell-Based Screening 2026

ELRIG, a not-for-profit, volunteer-led organization dedicated to the global drug discovery community, today announced the keynote speakers for Advances in Cell-based Screening 2026, taking place at AstraZeneca in Gothenburg, Sweden from 6-7 May.

From ELRIG (UK) Ltd. 12 Mar 2026

iXCells Biotechnologies reaches iPSC line delivery milestone in collaboration with global biotechnology company

iXCells Biotechnologies USA, Inc. ("iXCells"), a leading provider of human cell-based solutions and custom iPSC services, today announced the delivery of over 500 characterized induced pluripotent stem cell (iPSC) lines as part of a multi-year collaboration with a global biotechnology company.

From iXCells Biotechnologies 12 Mar 2026

mAbxience selects Genedata Bioprocess to automate end-to-end CDMO workflows

Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that mAbxience has selected the Genedata Bioprocess® enterprise platform to structure and harmonize all bioprocess development data across its operations.

From Genedata AG 11 Mar 2026

Machine learning model predicts chemical reactions to accelerate drug discovery

Drug discovery is like molecular Tetris. Chemists snap atoms together, adjusting the pieces until everything fits and suddenly, a molecule makes a promising new medicine.

9 Mar 2026

Researchers develop non-hormonal contraceptives to reduce side effects for couples

In the 1970s, the contraceptive pill was the most frequently used method of contraception in Western countries; in Germany, for example, one in three women used "the pill."

6 Mar 2026

Drug Discovery & Pharmaceuticals

PRISM ALS: A new global collaboration to expand patient-derived stem cell models and accelerate treatments

Purdue University accelerates rare disease drug discovery with the WELLJET dispenser stacker

Semarion secures $3.8 million to scale next-generation cell assay technology and accelerate pharma adoption

Nuclera launches GPCR-focused nanodisc panel to streamline membrane protein production

iXCells Biotechnologies joins international collaboration to evaluate chemotherapeutic toxicity in human organoids

Optibrium introduces graphical interface for QuanSA to enhance ligand-based affinity predictions

New nanoparticle system boosts scalable production of therapeutic exosomes

Insilico and ASKA partner to advance AI-driven gynecological drug discovery

Machine learning speeds up AMP discovery for treating ulcerative colitis

LGM Pharma expands U.S. manufacturing, bringing total investment to $15M across Texas and Colorado sites

Scientists turn plastic waste into Parkinson’s drug levodopa using engineered bacteria

New release Wiley's Mass Spectra of Designer Drugs 2026 expands coverage of emerging novel psychoactive substances

Researchers achieve breakthrough in the production of vital chemotherapy agent

Review examines clinical trial phases in drug development

Cambridge’s LED breakthrough reinvents drug synthesis

ELRIG announces Prof Hazel Screen and Dr Dave Powell as keynote speakers for Advances in Cell-Based Screening 2026

iXCells Biotechnologies reaches iPSC line delivery milestone in collaboration with global biotechnology company

mAbxience selects Genedata Bioprocess to automate end-to-end CDMO workflows

Machine learning model predicts chemical reactions to accelerate drug discovery

Researchers develop non-hormonal contraceptives to reduce side effects for couples

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest Life Science News